Clinical Trials Directory

Trials / Terminated

TerminatedNCT04429685

The Effects of Low Dose Ketamine on Cardiovascular Function

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
6 (actual)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Low dose ketamine is used for pain management and for the treatment of anxiety and depression. Prior studies on low dose ketamine have noted short-term (minutes to hours) increases or decreases in blood pressure. Blood pressure that is too high or too low can be problematic if untreated. It is unknown exactly how low dose ketamine affects blood pressure. In fact, no prior studies have measured sympathetic nervous system activity after low dose ketamine has been given to an adult. Because sympathetic nervous system activity has a large influence on blood pressure, we need to know how exactly low dose ketamine affects these body systems. Therefore, in this research we will study how low dose ketamine affects sympathetic nervous system activity and cardiovascular function. The results from this research will inform doctors about how low dose ketamine affects the sympathetic nervous system, heart, and blood vessels.

Conditions

Interventions

TypeNameDescription
DRUGKetamineLow dose ketamine - Ketalar (Racemic Ketamine Hydrochloride) Saline - Isotonic/Normal Saline
DRUGSaline (placebo)Saline (placebo)

Timeline

Start date
2020-11-01
Primary completion
2021-05-28
Completion
2021-05-28
First posted
2020-06-12
Last updated
2024-05-21

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04429685. Inclusion in this directory is not an endorsement.